Volume 11, Issue 1 - July 2021
UC Davis Clinical and Translational Science Center
Awarded 5-Year Grant Renewal From NIH
On June 17, 2021, the UC Davis Clinical and Translational Science Center (CTSC) received notice of its third National Institutes of Health (NIH) award renewal, a vote of confidence in the center’s ability to advance outstanding research in human health.
The 5-year award, almost $33 million, comes from NIH’s National Center for Advancing Translational Science (NCATS). It provides critical funding to the CTSC to continue its essential services for the UC Davis research community.
"We are so proud of our CTSC faculty and staff who put every effort in building the translational research culture at UC Davis,” said Allison Brashear, dean of UC Davis School of Medicine. “This NIH grant renewal for the CTSC recognizes the value of their contributions in promoting distinguished health scholarship and in reducing health disparities.”
Ulfat Shaikh Appointed to the Children’s Hospitals Association’s Next Generation of Quality Committee
The School of Medicine announced the first awardees of its new Cultivating Team Science seed grant program to incentivize collaborative science, which received 23 research proposals.
Sergio Aguilar-Gaxiola, professor of clinical internal medicine with the School of Medicine, has been chosen to receive the 2021 Hibbard Williams Extraordinary Achievement Award.
Heather Siefkes, assistant professor in the department of pediatrics, has received the 2021 Eli Gold Prize. The annual award of $3,000 supports winners’ research and career development.
An international team of researchers, led by UC Davis Health, has developed a new therapeutic approach to treating psoriatic arthritis, a chronic inflammatory disease affecting the joints.